BIO Protocol: A Decentralized Research Platform Empowering Biotech Innovation through Blockchain

1. Project Overview

BIO Protocol is a decentralized science platform aimed at promoting funding, development, and intellectual property sharing in biotechnology research through a decentralized autonomous organization model. The project stems from the team's early experiences at Molecule and VitaDAO and will officially launch in 2024.

The goal of BIO Protocol is to address the issue of uneven funding distribution in traditional biomedical research, encouraging research into rare diseases, longevity studies, and emerging health challenges.

2. Project Development History

In early 2023, the team began building the De-Sci ecosystem to lay the foundation for future development.

In the second half of 2024, BIO Protocol was officially established to begin building the BioDAOs network and promote research projects in multiple scientific fields.

In November 2024, a certain platform made its first De-Sci investment in BIO Protocol.

In December 2024, the BIO Genesis token issuance will be completed, raising over $33 million, and an airdrop plan will be launched.

In January 2025, the BIO token will be launched on a certain trading platform, with plans to be released on the Ethereum, Solana, and Base networks.

3. Core Team

The core team of BIO Protocol is composed of senior experts in the fields of Blockchain and biotechnology:

• Paul Kohlhaas: Co-founder with extensive experience in the integration of Blockchain and biotechnology.
• Clemens Ortlepp: Co-founder and Chief Product Officer, focused on Decentralization technology innovation
• James Sinka: Responsible for research and development and community operations
• Jose Pinto: Legal Advisor, ensuring the project operates in compliance.
• Leonard Boltz: Product expert, dedicated to creating an exceptional user experience.
• Nate Hindman: Head of Growth, responsible for expanding project influence.

Four, Business Model

BIO Protocol, as the financial layer of decentralized science, aims to accelerate the inflow of capital and talent into on-chain science. Its core functions include:

1. Curating: BIO token holders participate in selecting new BioDAOs to join the ecosystem.
2. Funding: Provide initial financing for accepted BioDAOs
3. Liquidity Management: Managing the liquidity of the BioDAO secondary market.
4. Bio/acc rewards: Incentivizing BioDAOs to achieve key milestones
5. Meta Governance: Empower BIO holders to govern a wide range of BioDAOs and scientific IP assets.

5. Ecological Construction

The ecological core of the BIO Protocol relies on the BioDAO network. Each BioDAO focuses on different sub-scientific fields, with members including patients, scientists, and biotechnology professionals from related areas. The project is designed with precise mechanisms to guide funding towards specific scientific missions or individual IP assets.

6. Successful Cases

1. VitaDAO: Provides over $5 million in funding support for longevity science research.
2. HairDAO: Focused on hair loss issues, with patents and consumer products.
3. CerebrumDAO: Promoting brain health research, raising over $1.5 million
4. ValleyDAO: Focused on synthetic biology, raised over $2 million
5. AthenaDAO: Promoting women's health research, funding $500,000 for translational research
6. CryoDAO: Promoting the development of low-temperature science, raising over $3 million.
7. PsyDAO: Focused on psychedelic drug research, launched the OPSY platform.

7. Token Economics

$BIO is the native governance token of BIO Protocol, and holders can participate in network governance, early financing, and receive economic rewards.

Initial allocation:

• Total Supply: 3,320,000,000
• Circulating Supply: 39.05%
• Maximum supply: Unlimited, determined by governance voting

Genesis Token Distribution:

• Community: 56%
• Early supporters: 13.6%
• Early Contributors: 21.2%
• Consultant: 4.2%
• Molecule: 5%

$BIO Unlock Plan: Tokens from all parties will be unlocked over a period of 1 to 6 years.

8. Development Prospects

The DeSci industry is in the early stages of rapid development, and BIO Protocol, as an important innovator, has significant potential in this market. The project's short-term goals include expanding the BioDAOs network, launching user-friendly tools, and promoting ecological development through token incentives. The long-term goal is to become a leader in the DeSci field, promote the transformation of research results, and collaborate with traditional institutions to promote a decentralized research model.

Overall, $BIO has a high long-term investment value, but the initial price fluctuations may be significant. As the first DeSci project to issue tokens on a certain platform, it is recommended to assign a certain valuation premium. Investors can allocate $BIO based on their risk preferences.